Scorpius Holdings Inc (SCPX)
0.0315
0.00 (0.00%)
USD |
NYAM |
Jun 24, 16:00
Scorpius Holdings Total Assets (Quarterly): 50.50M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 50.50M |
December 31, 2023 | 51.04M |
September 30, 2023 | 69.92M |
June 30, 2023 | 80.18M |
March 31, 2023 | 91.52M |
December 31, 2022 | 104.40M |
September 30, 2022 | 120.16M |
June 30, 2022 | 131.85M |
March 31, 2022 | 114.27M |
December 31, 2021 | 120.96M |
September 30, 2021 | 132.66M |
June 30, 2021 | 138.79M |
March 31, 2021 | 144.47M |
December 31, 2020 | 124.19M |
September 30, 2020 | 129.71M |
June 30, 2020 | 58.15M |
March 31, 2020 | 37.82M |
December 31, 2019 | 25.96M |
September 30, 2019 | 24.45M |
June 30, 2019 | 29.70M |
March 31, 2019 | 33.90M |
December 31, 2018 | 37.76M |
September 30, 2018 | 32.33M |
Date | Value |
---|---|
June 30, 2018 | 37.46M |
March 31, 2018 | 19.46M |
December 31, 2017 | 20.19M |
September 30, 2017 | 14.72M |
June 30, 2017 | 17.06M |
March 31, 2017 | 12.02M |
December 31, 2016 | 8.897M |
September 30, 2016 | 9.792M |
June 30, 2016 | 8.234M |
March 31, 2016 | 13.16M |
December 31, 2015 | 13.22M |
September 30, 2015 | 16.66M |
June 30, 2015 | 20.95M |
March 31, 2015 | 22.83M |
December 31, 2014 | 15.92M |
September 30, 2014 | 16.74M |
June 30, 2014 | 18.05M |
March 31, 2014 | 20.40M |
December 31, 2013 | 23.02M |
September 30, 2013 | 24.42M |
June 30, 2013 | 3.603M |
March 31, 2013 | 5.176M |
December 31, 2012 | 0.1476M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
24.45M
Minimum
Sep 2019
144.47M
Maximum
Mar 2021
89.04M
Average
97.96M
Median
Total Assets (Quarterly) Benchmarks
Biolase Inc | 34.35M |
GT Biopharma Inc | 9.912M |
Akoya Biosciences Inc | 154.75M |
NovaBay Pharmaceuticals Inc | 5.357M |
Palatin Technologies Inc | 11.41M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 25.24M |
Shareholders Equity (Quarterly) | 28.60M |
Debt to Equity Ratio | 0.0728 |
Current Ratio | 0.3768 |
Net Debt Paydown Yield | -7.13% |